Trials / Unknown
UnknownNCT05919641
LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT
LIVELUNG - Impact of CGA on QoL, Overall Survival and the Need for Admission in Patients Diagnosed With Localized NSCLC Treated With SBRT - a National Randomized Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
Older patients with non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) often die from other causes than lung cancer due to age-related comorbidities. This national randomized study will include 130 patients throughout 5 Danish cancer centres and investigate if a comprehensive geriatric intervention (CGA) when added upfront to SBRT for patients with localized NSCLC will have an impact on quality of life (QoL), overall survival, physical functionality and unplanned hospital admissions. If an upfront CGA improves patients' general health status, this study could lead to implementation of a CGA in standard clinical practice as well as further research on older patients receiving radiotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Comprehensive Geriatric Assessment | Comprehensive geriatric assessment (CGA) is defined as a multidisciplinary diagnostic and treatment process that identifies medical, psychosocial, and functional capabilities of an older adult in order to develop a coordinated plan to maximize overall health with aging. |
Timeline
- Start date
- 2020-09-29
- Primary completion
- 2024-04-01
- Completion
- 2025-04-01
- First posted
- 2023-06-26
- Last updated
- 2023-06-26
Locations
4 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05919641. Inclusion in this directory is not an endorsement.